149 related articles for article (PubMed ID: 10429716)
1. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy.
Orel SG; Weinstein SP; Schnall MD; Reynolds CA; Schuchter LM; Fraker DL; Solin LJ
Radiology; 1999 Aug; 212(2):543-9. PubMed ID: 10429716
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of the breast in patients with occult primary breast carcinoma.
Morris EA; Schwartz LH; Dershaw DD; van Zee KJ; Abramson AF; Liberman L
Radiology; 1997 Nov; 205(2):437-40. PubMed ID: 9356625
[TBL] [Abstract][Full Text] [Related]
3. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results.
Lee SG; Orel SG; Woo IJ; Cruz-Jove E; Putt ME; Solin LJ; Czerniecki BJ; Schnall MD
Radiology; 2003 Mar; 226(3):773-8. PubMed ID: 12601182
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.
Fischer U; Kopka L; Grabbe E
Radiology; 1999 Dec; 213(3):881-8. PubMed ID: 10580970
[TBL] [Abstract][Full Text] [Related]
6. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography.
Ko EY; Han BK; Shin JH; Kang SS
Korean J Radiol; 2007; 8(5):382-9. PubMed ID: 17923780
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
8. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy.
Orel SG; Schnall MD; Powell CM; Hochman MG; Solin LJ; Fowble BL; Torosian MH; Rosato EF
Radiology; 1995 Jul; 196(1):115-22. PubMed ID: 7784554
[TBL] [Abstract][Full Text] [Related]
9. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging for axillary staging in patients with breast cancer.
Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
[TBL] [Abstract][Full Text] [Related]
11. Laser therapy for breast cancer: MR imaging and histopathologic correlation.
Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG
Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910
[TBL] [Abstract][Full Text] [Related]
12. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability.
Scaranelo AM; Eiada R; Jacks LM; Kulkarni SR; Crystal P
Radiology; 2012 Feb; 262(2):425-34. PubMed ID: 22143924
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.
Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF
Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922
[TBL] [Abstract][Full Text] [Related]
15. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
[TBL] [Abstract][Full Text] [Related]
16. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
[TBL] [Abstract][Full Text] [Related]
17. Detection of breast malignancy: diagnostic MR protocol for improved specificity.
Huang W; Fisher PR; Dulaimy K; Tudorica LA; O'Hea B; Button TM
Radiology; 2004 Aug; 232(2):585-91. PubMed ID: 15205478
[TBL] [Abstract][Full Text] [Related]
18. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
19. Breast conservation treatment for patients presenting with axillary lymphadenopathy from presumed primary breast cancer: the role of breast magnetic resonance imaging for staging.
Chen C; Orel SG; Schnall MD; Harris E; Solin LJ
Clin Breast Cancer; 2002 Aug; 3(3):219-22. PubMed ID: 12196282
[TBL] [Abstract][Full Text] [Related]
20. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma.
Lieberman S; Sella T; Maly B; Sosna J; Uziely B; Sklair-Levy M
Isr Med Assoc J; 2008 Jun; 10(6):448-52. PubMed ID: 18669145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
